Document Detail


Cytostatic concentrations of anticancer agents do not affect telomerase activity of leukaemic cells in vitro.
MedLine Citation:
PMID:  10448276     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Telomerase, the enzyme that maintains the ends of linear eukaryotic chromosomes, is more active in the majority of malignant tumours than in normal somatic cells. Telomerase plays a key role in the maintenance of chromosomal stability in tumours, but it still remains unknown whether anticancer agents can inhibit telomerase activity. In this study, we evaluated the effect of various anticancer agents (etoposide, cisplatin, irinotecan, mitomycin C and daunorubicin) on the telomerase activity of three human haematopoietic cancer cell lines (Daudi, K562 and U937). A decrease of telomerase activity was not observed in cells treated with IC50 doses of the drugs, except for irinotecan-treated Daudi cells and daunorubicin- and irinotecan-treated U937 cells. Propidium iodide staining disclosed that the cells with decreased telomerase activity were severely damaged. U937 cells exposed to 5 microM (IC90) etoposide showed three different stages of cell viability during treatment. Apoptotic cells with an intact plasma membrane still maintained high telomerase activity, while cells with plasma membrane damage lost telomerase activity. The mRNA of the telomerase catalytic subunit (hTERT) showed a decrease in expression along with the decline of telomerase activity. These results indicate that the concentrations of drugs resulting in cytostatic effects on cells do not affect telomerase activity.
Authors:
M Akiyama; J Horiguchi-Yamada; S Saito; Y Hoshi; O Yamada; H Mizoguchi; H Yamada
Related Documents :
16154306 - The limitations and validities of senescence associated-beta-galactosidase activity as ...
16151516 - Uncoupling of longevity and telomere length in c. elegans.
18715936 - Htert alone immortalizes epithelial cells of renal proximal tubules without changing th...
15486186 - A g-quadruplex telomere targeting agent produces p16-associated senescence and chromoso...
20016286 - The popx2 phosphatase regulates cancer cell motility and invasiveness.
8280856 - Hair cell overproduction in the developing mammalian cochlea in culture.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of cancer (Oxford, England : 1990)     Volume:  35     ISSN:  0959-8049     ISO Abbreviation:  Eur. J. Cancer     Publication Date:  1999 Feb 
Date Detail:
Created Date:  1999-08-23     Completed Date:  1999-08-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9005373     Medline TA:  Eur J Cancer     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  309-15     Citation Subset:  IM    
Affiliation:
Department of Paediatrics, Jikei University School of Medicine, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / therapeutic use*
Apoptosis
DNA-Binding Proteins
Humans
Leukemia / drug therapy,  enzymology*,  pathology
Lymphoma / drug therapy,  enzymology*,  pathology
Neoplasm Proteins / antagonists & inhibitors*,  metabolism
RNA*
RNA, Messenger / metabolism
RNA, Neoplasm / metabolism
Telomerase / antagonists & inhibitors*,  metabolism
Tumor Cells, Cultured
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/DNA-Binding Proteins; 0/Neoplasm Proteins; 0/RNA, Messenger; 0/RNA, Neoplasm; 0/telomerase RNA; 63231-63-0/RNA; EC 2.7.7.49/Telomerase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Analysis of aberrant transcription of TSG101 in hepatocellular carcinomas.
Next Document:  Mutations in mitochondrial control region DNA in gastric tumours of Japanese patients.